Shared on 01 Nov 25

Fair value Increased 0.90%

Analysts have slightly raised their price target for Agilent Technologies from $148.57 to $149.90, citing stable fundamentals and a modest valuation adjustment. What's in the News Adam S.

Shared on 18 Oct 25

Fair value Increased 5.39%

Global Healthcare Demand And PFAS Testing Will Drive Analytical Progress

Analysts have raised their price target for Agilent Technologies from $140.97 to $148.57, citing improved revenue growth prospects and higher expected profit margins as key drivers behind the upward revision. What's in the News Announced launch of Insight Series Alarm Resolution Systems, which enhance airport security checkpoints with advanced liquid explosive detection and adaptability to changing regulations (Product Related Announcements).

Shared on 04 Oct 25

Fair value Increased 1.54%

Global Healthcare Demand And PFAS Testing Will Drive Analytical Progress

Agilent Technologies received a modest analyst price target increase from $138.83 to $140.97. This reflects analysts' expectations for stable growth and slightly improved long-term valuation metrics.

Shared on 16 Sep 25

Fair value Increased 0.48%

Global Healthcare Demand And PFAS Testing Will Drive Analytical Progress

Agilent Technologies’ fair value estimates have remained stable, as reflected by marginal changes in both the consensus analyst price target (up slightly to $138.83) and the forward P/E (now 27.33x). What's in the News Raised full-year 2025 revenue guidance to $6.91–$6.93 billion, up 6.2–6.5% reported and 4.3–4.6% core, reflecting a $150 million increase at the midpoint and 1.5 points higher core growth.

Shared on 07 May 25

Fair value Decreased 4.95%